Abstract
Objective:
To provide an overview of the degree of treatment goal achievement and drug prescribing in patients with coronary heart disease (CHD) in clinical practice.
Method:
Patients undergoing planned or acute percutaneous coronary intervention (PCI) were included. Patients’ medical records and the hospital’s database on clinical chemistry analyses were studied retrospectively.
Main outcome measure
Goal achievement and drug prescription relative to published therapeutic guidelines.
Results
A total of 200 patients aged 66 ± 11 years were included. Blood pressure <140/90 mmHg was achieved in 36% of patients 3 months after PCI and total cholesterol <5 mmol/l was achieved in 29% at the time of PCI. Three months after PCI the patients were on 1.4 (range 0–4) drugs with antihypertensive effect (including diuretics). Seventy eight percent were on a statin, 92% were on low-dose aspirin, and 23% had a diuretic in their drug regimen. Five out of 16 patients with diabetes mellitus included in the study were prescribed an angiotensin converting enzyme-inhibitor (ACE-I).
Conclusion:
There is probably a potential for increased degree of goal achievement and for improved drug prescribing in patients with CHD undergoing PCI at our hospital.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
SD Fihn MPH Sankey J Daley RJ Gibbons (2001) ArticleTitleGuidelines for the management of patients with chronic stable angina: treatment Ann Intern Med 135 616–32 Occurrence Handle11601935 Occurrence Handle1:CAS:528:DC%2BD3MXnvF2lsrc%3D
ME Elst ParticleVan der H Buurma ML Bouvy A Boer Particlede (2003) ArticleTitleDrug therapy for prevention of recurrent myocardial infarction Ann Pharmacother 37 1465–77 Occurrence Handle14519050
AV Chobanian GL Bakris HR Black WC Cushman LA Green JL Izzo et al. (2003) ArticleTitleThe seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure JAMA 289 IssueID19 2560–72 Occurrence Handle10.1001/jama.289.19.2560 Occurrence Handle12748199 Occurrence Handle1:CAS:528:DC%2BD3sXjvFCqtrk%3D
2003 European society of hypertension – European society of cardiology guidelines for the management of arterial hypertension. Guidelines committee. J Hypertens 2003; 21: 1011–53
B Williams NR Poulter MJ Brown M Davis GT McInnes JF Potter et al. (2004) ArticleTitleBritish hypertension society guidelines for hypertension management 2004 (BHS-IV): summary BMJ 328 634–40 Occurrence Handle15016698
The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413–46
D Wood G Backer ParticleDe O Færgeman I Graham G Mancia K Pyörälä et al. (1998) ArticleTitlePrevention of coronary heart disease in clinical practice. Recommendations of the second joint task force of European and other societies on coronary prevention Eur Heart J 19 1434–503
Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes care 2003; 26: S5–20
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7–22
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Giverhaug, T., Bruland, C. & Trovik, T. Secondary Prevention in Coronary Heart Disease: Goal Achievement and Drug Prescribing. Pharm World Sci 27, 472–474 (2005). https://doi.org/10.1007/s11096-005-1312-1
Issue Date:
DOI: https://doi.org/10.1007/s11096-005-1312-1